Search Results 91-100 of 16298 for Cystinosis%2Bagents

  1. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    About this study. Study AG221-C-001 is a Phase 1/2, multicenter, open-label, dose-escalation, safety, PK/PD, and clinical activity evaluation of orally ...

  2. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

    About this study. This is a randomized, double-blinded study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab ...

  3. Drugs and Supplements that Start with L - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “L” to learn about drug side effects, proper use and ...

  4. NL-201 in Patients With Relapsed or Refractory Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  6. Drugs and Supplements that Start with T - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “T” to learn about drug side effects, proper use and ...

  7. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  8. Rigorous science in regenerative medicine - Regenerative Neurosurgery and Neuro-Oncology Lab - Mayo Clinic Research

    Investigators in the Regenerative Neurosurgery and Neuro-Oncology Lab have cast doubts on commonly used markers to gauge stem cell plasticity.

  9. Non Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  10. Safety And Efficacy Study Of Filgotinib, GS-9876 And Tirabrutinib In Adults With Active Sjogren's Syndrome - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...